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Miao Zhang,1,2* Xuan-Yu Meng,1† Ji-fang Zhang,3,4 Meng Cui,1 Diomedes E. Logothetis1*
Phosphatidylinositol 4,5-bisphosphate (PIP2) directly interacts with the small-conductance Ca2+-activated K+ 2-a
(SK2-a) channel/calmodulin complex, serving as a critical element in the regulation of channel activity. We report
that changes of protein conformation in close proximity to the PIP2 binding site induced by a small-molecule SK
channel modulator, NS309, can effectively enhance the interaction between the protein and PIP2 to potentiate channel activity. This novel modulation of PIP2 sensitivity by small-molecule drugs is likely not to be limited in its application to SK channels, representing an intriguing strategy to develop drugs controlling the activity of the large
number of PIP2-dependent proteins.

INTRODUCTION
The small- and intermediate-conductance Ca2+-activated K+ (SK/IK)
channels play important roles in the regulation of membrane excitability by Ca2+ (1–4). Activation of SK channels by small molecules in the
nucleus accumbens region of the brain could help treat alcohol addiction (5). Administration of positive SK channel modulators is beneficial in animal models of neurodegenerative diseases, such as ataxia (6).
Tremendous effort has been devoted to developing small molecules
targeting SK/IK channels, including the most potent positive modulator NS309 (7–13), that enhance SK/IK channel activity through
allosteric modulation. Some of these compounds, such as chlorzoxazone and riluzole (Rilutek), have been used in multiple clinical trials
for neurological disorders, such as alcoholism and cerebellar ataxia
(http://clinicaltrials.gov/).
SK/IK channels are not voltage-dependent but are exclusively activated by Ca2+-bound calmodulin (CaM) tethered to the CaM-binding
domain (CaMBD) located at the C terminus of the channel (14, 15).
Binding of Ca2+ to CaM causes significant changes in the conformations
for both CaM and CaMBD, leading to formation of a complex between
CaM and CaMBD (16–18). CaM associated with CaMBD is responsible for Ca2+ sensing, whereas the transmembrane helices are the place
where mechanical gating occurs. Between the S6 (the last transmembrane helix) and the CaMBD lies the channel fragment R396-M412,
the conformation of which is critical for the coupling between Ca2+
sensing by CaM and channel opening (19). Pharmacological intervention with NS309 stabilizes this channel fragment and facilitates channel opening. However, it has remained unknown which
physiological factor is responsible for the coupling. Here, we show
that phosphatidylinositol 4,5-bisphosphate (PIP2) is the physiological
1
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regulator that modulates the coupling to channel opening and that
NS309 enhances the PIP2 interactions with the CaM/SK2 complex
to exert its effect.

RESULTS
The influence of NS309 on the intrinsically disordered
protein fragment conformation of the SK2-a channel
The SK2 channel opens in response to elevated intracellular Ca2+
levels. Ca2+ binds to CaM associated with CaMBD at the channel C
terminus and induces conformational changes. The Ca2+-induced conformational changes are transmitted to the transmembrane domains
through an SK2 channel fragment. Part of this SK2 channel fragment
(E399-K402) forms a “cuff” that interacts with the CaM linker region
between the N- and C-lobes. The rest (E404-M412) is highly flexible,
and as a result, its conformation could not be determined by x-ray
crystallography [Protein Data Bank (PDB): 4J9Y] in the absence of
NS309 (Fig. 1A). This highly flexible fragment exhibited the characteristics of an intrinsically disordered protein fragment (IDF) (19). For
instance, the side chain of E404 is highly flexible and cannot be determined beyond the b carbon. Along the direction of the b carbon, the
side chain was modeled with PyMOL. The putative E404 side chain
(d carbon) is 5.5 Å away from R471 (z carbon), suggesting a possible salt bridge between the two residues. We examined this possibility
using molecular dynamics (MD) simulations. Indeed, during a 20-ns
simulation, the distance between E404 and R471 mostly stayed below 5 Å, indicating a stable salt bridge (fig. S1A and Fig. 1A). In the
cocrystal structure with NS309 (PDB: 4J9Z), NS309 stabilizes the IDF,
and the electron density showed a well-structured IDF (Fig. 1C).
NS309 formed a hydrogen bond with K75 of CaM, which, in turn,
promoted the salt bridge E404-K75. Consistently, MD simulations
with NS309 showed that E404 no longer formed a salt bridge with
R471 (as it did in Fig. 1B in the absence of NS309), but rather it
formed a salt bridge with K75 (3.8 Å) (fig. S1B and Fig. 1D). NS309
left-shifted the Ca2+ median effective concentration (EC50) by about
sixfold from 0.32 ± 0.3 mM (n = 8) to 0.052 ± 0.03 mM (n = 5; P <
0.01) (Fig. 1, E and F), consistent with our previous work (19). The single
mutant E404A/C/D or K75C/R failed to be activated by Ca2+, whereas
the double mutant E404D/K75R rescued activation by Ca2+ and
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Fig. 1. Stabilization of IDF of SK2-a channel by NS309. (A) The IDF (dashed line) is highly flexible in the absence of NS309, and its structure could
not be determined by x-ray crystallography. (B) E404-R471 distance from MD simulation in the absence (black) and presence (red) of NS309. (C) The
IDF becomes well structured in the presence of NS309. NS309 forms contacts with F410. In addition, the E404-K75 salt bridge is promoted through a
hydrogen bond between NS309 and K75. (D) The E404-K75 distance from MD simulations in the absence (black) and presence (red) of NS309. (E) Doseresponse curves of channel reactivation by Ca2+ in the absence (solid line, filled symbols) and presence (dashed line, open symbols) of 3 mM NS309 of the
wild-type (WT)/WT (SK2-a/CaM) channel. (F) NS309 increases the apparent affinity for Ca2+ of SK2-a channels.

NS309, similarly left-shifting the Ca2+ EC50 by about sevenfold (19). It
was postulated that the salt bridge formation by these two residues
must be important for channel opening. However, interactions between a fluorophore-labeled CaM and the CaMBD of SK2-a showed
Zhang et al. Sci. Adv. 2015;1:e1500008
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no evidence for changes in Ca2+ binding by either NS309 or mutants
that produced clear changes in Ca2+ responses (19). These results suggested that NS309 and the IDF mutants acted downstream of Ca2+
binding, closer to the channel-gating machinery.
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We used MD simulations to examine interactions between PIP2 and its
binding site in the absence (Fig. 2, A and B) and presence (Fig. 2, C and D)

of NS309. Without NS309, the P4 phosphate of PIP2 primarily interacts
with K402 and K405, whereas P5 forms salt bridges with K77 and K402
(Fig. 2B). In the presence of NS309, a strengthened salt bridge between
the P5 of PIP2 and K405 of the IDF was observed (Fig. 2D). The histogram of the P5-K405 distance from the MD simulations confirmed the
clear difference between the presence and absence of NS309 (fig. S3A).
In the absence of NS309, the P5-K405 distance broadly distributes, with the
major peak larger than 7 Å. With NS309, the P5-K405 distance peaks at
3.8 Å, clearly showing a high probability for salt bridge formation (fig. S3A).
The distances between P5-K402, P4-K405, and P4-K402 are not essentially
affected by NS309 (fig. S3, B to D, and Fig. 2, A and B versus C and D).
Our previous work (19, 27) has suggested that both NS309 and
PIP2 are involved in the coupling between Ca2+ sensing by CaM and
channel gating. Together with the proximity of their binding sites
(Fig. 2C), this overlap in their function motivated us to test whether
NS309 cooperates with PIP2 in modulation of SK2-a channel activity.
It is clear that PIP2 alone is effective in this coupling to channel opening
because the channel can open in the absence of NS309. However, it is
unknown whether NS309 can replace PIP2 and open the channel in the
absence of PIP2. SK channel currents were recorded using inside-out
patches, as previously described (18, 19, 28). Upon application of polylysine (poly-K, 900 mg/ml), shown to sequester endogenous PIP2
(29, 30), the current was almost completely inhibited (Fig. 3A). Saturating concentrations of Ca2+ (2 mM) and NS309 (3 mM) were applied
to the cytoplasmic side of the patch but failed to induce any current
(Fig. 3A), suggesting that PIP2 could not be replaced by NS309 in coupling Ca2+ binding to SK2-a channel opening.
Because NS309 could not replace PIP2, its potentiation of channel
activity could be working through an increase in PIP2 sensitivity. To

K77

PIP2 in regulation of SK2-a channel
R396 is the last residue of the S6 transmembrane domain, which
makes the CaM linker, the cuff (E399-K402), and IDF (E404-M412)
accessible to the inner leaflet of the plasma membrane. This region is
rich in positively charged residues. In the past couple of decades, it has
been established that plasma membrane phosphoinositides, mainly
PIP2, can regulate the activities of many different types of ion channels
(20–22). The PIP2 binding site consists of positively charged amino
acid residues clustered close to the bottom of the pore-forming S6
segments and the immediate C-linker region connecting the S6 transmembrane domain to the cytosolic domain of each channel protein
(23–26). As Fig. 2A shows, with combined approaches of MD simulation and site-directed mutagenesis, we recently identified a putative
binding site for PIP2 in SK2-a channels, which involves K402 and
K405 from the channel, in addition to K77 and R74 (not shown) of
the CaM linker region (27). This region is distant from the Ca2+binding sites (EF hands) of CaM. Because residues in this region were
shown not to interfere with Ca2+ binding (19), PIP2 could serve as the
physiological regulator responsible for the coupling between the Ca2+
binding of CaM and the mechanical opening of the channel pore. In
MD simulations, PIP2 prominently influenced the conformation of
E404. PIP2 disrupted the E404-K471 salt bridge (fig. S2A), whereas
it promoted the E404-K75 salt bridge (Fig. 2A and fig. S2B), similar
to the effect of NS309.
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Fig. 2. The effect of NS309 on PIP2 interactions with SK2-a channel. (A) A representative snapshot from MD simulations of PIP2 (P4 and P5 in orange
and oxygens in red) binding to CaM (salmon) and SK2-a channel (gray) in the absence of NS309. (B) Summarized probability of forming salt bridges
between PIP2 head and positively charged residues in the absence of NS309. (C) A representative snapshot from MD simulations of PIP2 (P4 and P5
in orange and oxygens in red) binding to CaM and SK2-a channel (gray) in the presence of NS309 (yellow). Salt bridges are shown as blue dashed
lines with distances in angstrom. (D) Summarized probability of forming salt bridges between the PIP2 head and positively charged residues in the
presence of NS309.
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Fig. 3. The effect of NS309 on PIP2 sensitivity of the SK2-a channel. (A) Raw current traces before (black) and after (red) application of poly-K in the
presence of 2 mM Ca2+. After depletion of endogenous PIP2, 2 mM Ca2+ and 3 mM NS309 (green) could not induce any measurable current increase. (B)
Dose-dependent channel reactivation by exogenous diC8-PIP2 at the indicated concentrations, in the presence of 3 mM NS309, after depletion of the
endogenous PIP2 by poly-K. (C) Dose-response curves of channel reactivation by exogenous diC8-PIP2 in the absence (solid line) and presence (dashed
line) of 3 mM NS309 on WT/WT (SK2-a/CaM) channel. (D) NS309 increases the apparent affinity for diC8-PIP2 of SK2-a channels.

evaluate the effect of NS309 on PIP2 sensitivity, a water-soluble, synthetic PIP2 derivative, diC8-PIP2, together with NS309 (3 mM) and Ca2+
(2 mM), was gradually applied to the bath solution once the sequestration of the endogenous PIP2 by poly-K was achieved (Fig. 3B). Application of diC8-PIP2 restored the SK current in a dose-dependent
manner (Fig. 3, B and C), with the EC50 for diC8-PIP2 at 1.9 ± 0.22 mM
in the absence of NS309 (n = 6; Fig. 3, C and D). In the presence of
NS309 (3 mM), the dose-response curve of diC8-PIP2 was left-shifted
(Fig. 3C), with the EC50 for diC8-PIP2 at 0.24 ± 0.04 mM (n = 4; P <
0.01; Fig. 3, C and D).
SK2-a channels have been shown to be regulated by phosphorylation or dephosphorylation (31–33). Phosphorylation of CaM at T79
by casein kinase II reduces the Ca2+ sensitivity of the SK2-a/CaM
complex for channel activation (32). CaM T79 is located in the vicinity
of the PIP2 binding site (Fig. 2A). Mimicked by T79D, its phosphorylation can significantly reduce the apparent affinity of PIP2 for its binding site and therefore exert its inhibitory effect on channel activity (27).
In response to neurotransmitters such as noradrenaline and acetylcholine, the SK channel/CaM complex undergoes phosphorylation
at T79, which results in inhibition of SK channel activity (33–35).
The question arises whether this phosphorylated form of the SK2-a
Zhang et al. Sci. Adv. 2015;1:e1500008
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channel/CaM complex is sensitive to pharmacological intervention
using small molecules such as NS309. We set out to clarify this question with the phosphomimetic T79D mutant channel. NS309 (3 mM)
significantly reduced the EC50 for PIP2 on the T79D mutant channel
(1.89 ± 0.36 mM; n = 5; P = 0.005) compared with 22.1 ± 2.22 mM
(n = 4) in the absence of NS309 (fig. S4, A and B). Under physiological
conditions, the CaM molecules complexed with the SK channel
undergo dynamic changes in their phosphorylation status (31, 32).
The capability of NS309 to modulate both the phosphorylated and
dephosphorylated channel complexes is of practical interest, considering the application of positive SK channel modulators in vivo as
potential therapeutic agents.
The phosphomimetic T79D mutation causes a substantial conformational change at the PIP2 binding site (fig. S5A) compared with the
WT/WT channel/CaM complex (Fig. 2A). The P4-K402 and P5-K77 interactions are weakened, whereas the P5-K405 interaction is strengthened
(Fig. 2B versus fig. S5B). T79D is neighbored by K402 and K77. The negative charge at T79D inevitably interferes with the P4-K402 and P5-K77
interactions, which are only partially compensated by the strengthened
P5-K405 interaction (fig. S5B). Overall, the PIP2 interaction is weakened
by the negative charge of T79D mutation. The binding of NS309 partially
4 of 8
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apparent affinity of PIP2, with EC50 at 14.2 ± 1.93 mM (n = 4; P <
0.001), 15.2 ± 2.14 mM (n = 4; P < 0.001), and 22.1 ± 2.22 mM
(n = 4; P < 0.001), respectively (Fig. 4A). We continued by testing
the effect of NS309 on these mutant channels (Fig. 4B). The EC50
values for NS309 in these mutant channels were significantly increased
compared to those in the WT/WT channel (0.24 ± 0.031 mM; n = 6).
The EC50 values of NS309 for the K402N, K405N, and T79D mutants
were 0.49 ± 0.047 mM (n = 5; P < 0.001), 0.46 ± 0.067 mM (n = 5; P =
0.002), and 0.67 ± 0.043 mM (n = 4; P < 0.001), respectively. There is a
clear correlation (R = 0.981) between the sensitivity of the mutant
channels toward NS309 and PIP2 (Fig. 4C). Figure 4D shows a simplified scheme for SK2-a channel activation, with Ca2+ binding to
CaM as the first step and the mechanical coupling to channel opening
as the second step. Both PIP2 and NS309 act on the second step. Because PIP2 is the necessary factor for the NS309 effect (Fig. 3A), a reasonable interpretation would be that NS309 facilitates regulation of
channel opening by PIP2 (Fig. 3D) and potentiates channel activity.
Although NS309 primarily strengthens the K405-P5 interaction as
shown in the MD simulation (Fig. 2D), K405N did not abolish the
potentiation of SK2-a channels by NS309. Rather, K405N mutation
reduces the potency of NS309 in a manner correlated to its weakening

restores the PIP2 interaction (fig. S5C). It causes a significant rearrangement
of the PIP2 binding site (fig. S5D versus fig. S5B). The P5-K402 interaction is weakened, whereas both the P4-K77 and the P4-K402 interactions are enhanced, resulting in a net gain in interaction with PIP2.
The enhancement of the P4-K77 (fig. S6A) and the P4-K402 (fig. S6B)
interactions is reflected by the shortening of their distance from each
other in the MD simulations. The weakening of the P5-K402 interaction is reflected by an increase in distance (fig. S6C). The P5-K405
distance is not affected by NS309 (fig. S6D).
Role of PIP2 in the effect of NS309
Because NS309 and Ca2+ cannot open the channel in the absence of
PIP2 (Fig. 3A), we turned to a different strategy to examine the role of
PIP2 in the effect of NS309. We identified several mutations that interfere with the regulation of the channel by PIP2, such as the SK2-a
K402, K405, and the phosphomimetic CaM T79D mutations (Fig. 4A).
The PIP2 sensitivity was determined through scavenging of endogenous PIP2 with poly-K and reintroducing it by subsequent application of
diC8-PIP2 in the bath solution, as in Fig. 3 (B and C). Compared with the
EC50 for diC8-PIP2 at 1.9 ± 0.22 mM for WT/WT channel (n = 6),
the mutations of K402N, K405N, and T79D significantly reduced the
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of channel-PIP2 interactions (Fig. 4C), suggesting the central role of
channel-PIP2 interactions in the mechanism of action of NS309.

DISCUSSION
NS309 enhances the Ca2+ sensitivity of SK channel and thus was previously speculated to change the Ca2+ binding to CaM associated with
SK channels. Subsequently, we suggested that NS309 does not influence the Ca2+ binding to CaM and the Ca2+-induced conformational
change of the CaM/CaMBD complex (19). Rather than Ca2+, here we
show that NS309 allosterically enhances the interactions of PIP2 with
the CaM/SK2 complex as its mechanism of action.
PIP2 is a necessary cofactor for the function of many ion channels,
regulating channel activity through direct interactions (20, 21). Considering this crucial role of PIP2-channel interactions in ion channel
function, changes in these interactions would inevitably influence
channel activity. Here, we have demonstrated that NS309 enhances
the PIP2 sensitivity of both the WT/WT channel/CaM complex
(Fig. 3) and a phosphomimetic CaM mutant/channel complex (fig.
S4) and thus positively modulates the SK channel activity. A recent
study has shown that PIP2 exists in the plasma membrane at nanoscale regions (36) and may reach relatively high local concentrations.
Neurotransmitters induce phosphorylation of CaM associated with SK
channels, which results in reduced PIP2 sensitivity of SK channels
(27). Meanwhile, the neurotransmitters such as acetylcholine may also
induce hydrolysis and thus reduce PIP2 levels (27). These synergistic
effects can potently inhibit SK channel activity. Under such circumstances, the ability of compounds to positively modulate the phosphorylated form (mimicked by T79D) of SK channels is essential
for their drug effects. To date, NS309 represents a unique example
of pharmacological modulation of ion channels by small molecules
through manipulation of channel-PIP2 interactions. However, it is unlikely that NS309 is the only compound that modulates channel activity through this mechanism. It will not be surprising if additional
drugs targeting ion channels are found to act on modulating
channel-PIP2 interactions. The present work ought to motivate the
development of new compounds targeting ion channels through allosteric weakening or enhancement of channel-PIP2 interactions. Recent
work from our group has shown that, in addition to ion channels,
other transmembrane proteins such as tyrosine kinase receptors
may also be regulated by PIP2 (37). Most recently, the psychostimulant amphetamine has been found to alter the PIP2 interaction of human dopamine transporter and trigger dopamine efflux (38).
Therefore, the strategy for developing drugs that modulate proteinPIP2 interactions is likely not to be limited to ion channels.

MATERIALS AND METHODS
Molecular biology and channel expression
Details can be found in our previous papers (18, 19, 28). Briefly, rat
SK2-a channels (accession no. NM_019314), along with CaM (accession no. NM_012518), were each subcloned into the pCDNA3.1(+)
expression vector (Invitrogen). Mutations were introduced into SK2a or CaM using the QuikChange XL Site-Directed Mutagenesis Kit
(Stratagene-Agilent) and subsequently confirmed by DNA sequencing.
Along with WT CaM or mutant CaM and green fluorescent protein,
Zhang et al. Sci. Adv. 2015;1:e1500008
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WT or mutant channels were expressed in TsA201 cells cultured in
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum and penicillin/streptomycin. The calcium phosphate method was used for transfection of SK2-a complementary DNA (WT or
mutants), together with WT CaM or mutant CaM and green fluorescent protein at a ratio of 5:2.5:1 (weight). SK channel modulator NS309
was from Tocris. DiC8-PIP2 was from Avanti Polar Lipids. Poly-K was
purchased from Sigma-Aldrich.
Electrophysiology
Channel activities were recorded with the inside-out patch clamp configuration 1 to 2 days after transfection, with a MultiClamp 700B or
an Axon 200B amplifier (Molecular Devices) at room temperature.
pCLAMP 10.2 (Molecular Devices) was used for data acquisition
and analysis. The resistance of the patch electrodes ranged from 3
to 6 megohms. The pipette solution contained 140 mM KCl, 10 mM
Hepes, and 1 mM MgSO4 (pH 7.4). The bath solution contained 140 mM
KCl and 10 mM Hepes (pH 7.2). EGTA (1 mM) and HEDTA (hydroxyethyl ethylenediaminetriacetic acid) (1 mM) were mixed with Ca2+ to obtain the indicated free Ca2+, calculated using the software by C. Patton
of Stanford University (www.stanford.edu/~cpatton/maxc.html). The
Ca2+ concentrations were verified using Fluo-4 and standard Ca2+ buffers (Molecular Probes). Currents were recorded by repetitive 1-s voltage ramps from −100 to +100 mV from a holding potential of 0 mV.
For dose-response curves of NS309 in the presence of Ca2+ (0.2 mM),
the current amplitudes at −90 mV in response to various NS309 concentrations were normalized to that obtained at a maximal NS309 concentration. The dose-response curves for diC8-PIP2 were obtained at
various diC8-PIP2 concentrations in the presence of 2 mM Ca2+, with
or without NS309 (3 mM) after successful depletion of the native PIP2
by poly-K (900 mg/ml) and subsequent washout of the poly-K. EC50s
for NS309 or diC8-PIP2 were determined by fitting the data points to
the Hill equation [Y = 100/(1 + (X/EC50)−Hill)].
Molecular docking
The molecular docking program AutoDock 4 (39) was used for the
docking of PIP2 into the structure of the CaM/CaMBD complex (4J9Z)
(19). The partial charges for PIP2 were obtained from ab initio quantum
chemistry at the Hartree-Fock (HF)/6-31+G* level using the CHELPG
(charges from electrostatic potentials using a grid-based method)
charge–fitting scheme (40) of Gaussian 98 program (41) as described
previously (42). Because the size of the PIP2 molecule is too large for
flexible docking studies, we replaced it with an analog (diC1), which
replaces the two long tails of PIP2 by two methyl groups. Grid potential maps were generated for the CaM/CaMBD complex using CHNOP
(that is, carbon, hydrogen, nitrogen, oxygen, and phosphorus) elements
sampled on a uniform grid containing 60 × 60 × 58 points, 0.375 Å apart.
The center of the grid box was set to a critical PIP2-sensitive residue,
K77. The Lamarckian genetic algorithm was selected to identify the
binding conformations of the ligands. The side chains for residues R74,
K77, K402, and K405 were set to be flexible. One hundred docking
simulations were performed, and the final docked diC1-PIP2 configurations were selected on the basis of docked binding energies and
relative orientation of the diC1-PIP2 to the CaM/CaMBD complex.
MD simulations
Complexes of CaM/CaMBD or CaM(T79D)/CaMBD and diC1-PIP2
in the presence and absence of NS309 were immersed in 0.15 M KCl
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virtual solution. The OPLS (optimized potentials for liquid simulations)
force field was used for CaM/CaMBD and diC1-PIP2, and the simple
point charge (SPC) model for water molecules. All MD simulations were
carried out using Desmond 3.1 (43). After being relaxed by the Desmond
standard NPT (constant number of atoms, pressure, and temperature)
relaxation protocol, complexes were subjected to 20-ns MD simulations
without any restraint at the constant temperature of 298 K. The distance
distribution histograms between different amino acid residues or between
amino acid residues and the PIP2 head were constructed and fit to Gaussian
distribution functions to obtain the mean distances. A total of 2001 models were generated during the MD simulation. Structure graphics were
created using PyMOL (Schrödinger, LLC).
Statistical analysis
All data are presented as means ± SEM. The Student t test was used
for data comparisons.

SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/1/6/e1500008/DC1
Fig. S1. The influence of NS309 on the conformation of IDF.
Fig. S2. The influence of PIP2 on the conformation of the IDF.
Fig. S3. The PIP2-channel interaction is affected by NS309.
Fig. S4. The effectiveness of NS309 on the phosphomimetic T79D CaM mutant.
Fig. S5. The proximity of NS309 and CaM T79D mutation to the PIP2 binding site.
Fig. S6. The PIP2-channel interaction is affected by NS309 in the context of T79D mutant.
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